Self-assembled prodrugs: An enzymatically triggered drug-delivery platform
Source abstract
Abstract
Enzyme catalysis as a tool to disassemble supramolecular hydrogels to control the release of encapsulated drugs provides an opportunity to design a wide range of enzyme-specific low-molecular-weight hydrogelators. In this proof-of-concept work, we report the synthesis of low-molecular-weight amphiphilic prodrugs as hydrogelators from a well-known drug acetaminophen (which belongs to a class of drugs called analgesics (pain relievers) and antipyretics (fever reducers)). We have shown the ability of prodrugs to self-assemble to form hydrogels that could subsequently encapsulate a second drug such as curcumin, which is a known chemopreventive and anti-inflammatory hydrophobic drug. Upon enzyme-triggered degradation, the hydrogel released single or multiple drugs at physiologically simulated conditions in vitro. Given that the degradation products consist of the drug and a fatty acid, this approach has an advantage over polymer-based prodrugs that generate polymer fragments with heterogeneous chain lengths upon degradation that may present complex toxicity profiles. Additionally, drug-release occurred without burst release. Spectrophotometric experiments supported the drug-release, and the rate was controlled by modulation of temperature and enzyme concentration. Mesenchymal stem cells treated with prodrugs retained their stem cell properties including the capacity of multi-lineage differentiation, and maintained their adhesive and proliferation capacities with high viability. The present biomaterials could have broad applications as drug-delivery vehicles and cell invasive matrices.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Hydrogels: synthesis, properties, applications · Advanced Materials and Mechanics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. 1987
2. Hydrogels in pharmaceutical formulations10.1016/S0939-6411(00)00090-4 ↗
3. Glucose-sensitivity of glucose oxidase-containing cationic polymer hydrogels having poly(ethylene glycol) grafts10.1016/S0168-3659(00)00195-4 ↗
4. Hydrogels: from controlled release to pH-responsive drug delivery10.1016/S1359-6446(02)02255-9 ↗
5. Biomolecule-sensitive hydrogels10.1016/S0169-409X(01)00241-1 ↗
6. Environment-sensitive hydrogels for drug delivery10.1016/S0169-409X(01)00203-4 ↗
7. Biodegradation of poly(anhydride-esters) into non-steroidal anti-inflammatory drugs and their effect on Pseudomonas aeruginosa biofilms in vitro and on the foreign-body response in vivo10.1016/j.biomaterials.2006.05.034 ↗
8. Degradable poly(anhydride ester) implants: effects of localized salicylic acid release on bone10.1016/S0142-9612(00)00118-6 ↗
9. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems10.1016/S0168-3659(01)00248-6 ↗
10. Hydrogels for tissue engineering10.1021/cr000108x ↗
11. Stimulus-sensitive hydrogels and their applications in chemical (micro)analysis10.1039/b210140h ↗
12. Review: hydrogels for cell immobilization10.1002/(SICI)1097-0290(19960520)50:4<357::AID-BIT2>3.0.CO;2-K ↗
13. Wang K, Burban J, Cussler E. Hydrogels as separation agents. Responsive gels: volume transitions II. 1993; 67–79.10.1007/BFb0021129 ↗
14. Next-generation hydrogel films as tissue sealants and adhesion barriers
15. Hydrogels in biology and medicine: from molecular principles to bionanotechnology10.1002/adma.200501612 ↗
16. Hydrogels in drug delivery: progress and challenges10.1016/j.polymer.2008.01.027 ↗
17. Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release10.1016/S0168-3659(98)00125-4 ↗
18. Enzymatic hydrogelation of small molecules10.1021/ar7001914 ↗
19. Using a kinase/phosphatase switch to regulate a supramolecular hydrogel and forming the supramolecular hydrogel in vivo10.1021/ja057412y ↗
20. Two-stage enzyme mediated drug release from LMWG hydrogels10.1039/b507157g ↗
21. Entrapment and release of quinoline derivatives using a hydrogel of a low molecular weight gelator10.1016/j.jconrel.2004.03.012 ↗
22. In situ synthesis of gold nanoparticles using molecular gels and liquid crystals from vitamin-c amphiphiles10.1021/cm062464n ↗
23. Smart amphiphiles: hydro/organogelators for in situ reduction of gold10.1039/b518289a ↗
24. Bhattacharya · 2004
25. Effective gelation of water using a series of bis-urea dicarboxylic acids10.1002/1521-3773(20001002)39:19<3447::AID-ANIE3447>3.0.CO;2-X ↗
26. Low molecular weight organogelators for water10.1039/b205733f ↗
27. Molecular design of “super” hydrogelators: understanding the gelation process of azobenzene-based sugar derivatives in water10.1021/ol025519+ ↗
28. Gelation-driven component selection in the generation of constitutional dynamic hydrogels based on guanine-quartet formation10.1073/pnas.0501663102 ↗
29. Anatomy of a gel. Amino acid derivatives that rigidify water at submillimolar concentrations10.1021/ja0016811 ↗
30. An attempt to predict the gelation ability of hydrogen-bond-based gelators utilizing a glycoside library10.1016/S0040-4020(00)00915-7 ↗
31. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis10.1016/S0959-8049(00)00156-8 ↗
32. Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies
33. Enzyme-catalyzed activation of anticancer prodrugs10.1124/pr.56.1.3 ↗
34. Pharmaceutical approaches to colon targeted drug delivery systems
35. Microbially triggered drug delivery to the colon10.1016/S0928-0987(02)00221-X ↗
36. Enzyme catalysis: tool to make and break amygdalin hydrogelators from renewable resources: a delivery model for hydrophobic drugs10.1021/ja062650u ↗
37. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain10.1016/0014-2999(96)00261-0 ↗
38. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H2 synthases10.1073/pnas.102588199 ↗
39. The fate of acetanilide in man10.1016/S0022-3565(25)03462-7 ↗
40. Synthesis and characterization of mPEG-PLA prodrug micelles10.1021/bm050188k ↗
41. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy10.1016/S0168-3659(01)00275-9 ↗
42. Frisch · 2003
43. Hehre · 1986
44. The monoclinic form of acetaminophen at 150K
45. How curcumin works preferentially with water soluble antioxidants10.1021/ja003823x ↗
46. Chemopreventive and therapeutic effects of curcumin10.1016/j.canlet.2004.09.041 ↗
47. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells10.1002/mc.10029 ↗
48. Photocytotoxicity of curcumin10.1111/j.1751-1097.1994.tb05036.x ↗
49. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin10.1016/S1074-5521(03)00169-8 ↗
50. Inhibition of human immunodeficiency virus type-1 integrase by curcumin10.1016/0006-2952(95)98514-A ↗
51. Inhibition of the HIV-1 and HIV-2 proteases by curcumin and curcumin boron complexes10.1016/S0968-0896(00)82152-5 ↗
52. Effect of solvent on the excited-state photophysical properties of curcumin10.1562/0031-8655(2000)072<0625:EOSOTE>2.0.CO;2 ↗
53. Study on the supramolecular interaction of curcumin and β-cyclodextrin by spectrophotometry and its analytical application10.1021/jf0111965 ↗
54. Enzymatic degradation of poly(ether urethane) and poly(carbonate urethane) by cholesterol esterase10.1016/j.biomaterials.2006.03.012 ↗
55. Multipotent adult progenitor cell and stem cell plasticity10.1385/SCR:1:1:053 ↗